Kim, K Jin <br/><br/>
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2006 
 - 1292-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-05-1793  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Apoptosis--drug effects<br/>Brain Neoplasms--pathology<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Endothelial Cells--cytology<br/>Female<br/>Glioma--pathology<br/>Hepatocyte Growth Factor--immunology<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mice, SCID<br/>Neutralization Tests<br/>Remission Induction<br/>Time Factors<br/>Xenograft Model Antitumor Assays--methods